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Volume 60, Number 4 Letters to the Editor 1121criteria used for native arteries. The criteria used in COBEST have
not been validated for diagnosis of restenosis after iliac artery stent-
ing or stent grafting. No data are provided as to the distribution of
the diagnostic modalities used to diagnose the stenoses in COB-
EST, nor do the authors provide data on how many patients had
conﬁrmation of the restenosis by angiography.
Finally, COBEST did not stratify patients on the basis of the
TransAtlantic Inter-Society Consensus (TASC) classiﬁcation, and
more than 60% of the patients had TASC B disease. Therefore,
the study is underpowered to make any meaningful conclusion
for the post hoc analysis of patients with TASC C and D disease
where the authors indicated a difference in binary restenosis
between the two stents.
Our study and COBEST have clearly sparked interest.
The DISCOVER6 trial will use some of the same end points as
COBEST and will be underpowered for subgroup analyses. On
the other hand, the planned assessment of quality of life and
walking scores may help determine whether restenosis is an
outcome that is important to patients.
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Regarding “Interfacility transfer and mortality
for patients with ruptured abdominal aortic
aneurysm”
We were pleased to read the systematic analysis concerning
interfacility transfer and mortality for patients with ruptured
abdominal aortic aneurysm (rAAA) by Mell et al.1 We do disagree,
however, with the ﬁrst part of the discussion stating that their
actual study was the ﬁrst to describe population-level outcomes
for patients with rAAAs, including patients transferred for care.
Our analysis,2 published in 2012, is based on the entire populationof Norway and describes incidence, handling, and outcome for pa-
tients with rAAA in Norway, including those transferred to
another hospital before operative repair.
Interestingly, the proportions of patients transferred for treat-
ment of rAAA, as well as the proportions of patients who under-
went rAAA repair after transfer, are similar in both studies. The
former is 19.1% in their study compared with 17.9% (87 of 487)
in our study, the latter is 83.3% (706 of 847) in their study
compared with 86.2% (75 of 87) in our study.1,2
Both studies indicate that most patients with rAAA can still be
treated after transfer, which is good news, bearing in mind that
centralization of vascular services leaves transfer and a subsequent
operation as the only treatment option for a growing number of
patients. Optimizing transfer time and communication between
hospitals, including shared imaging, enabling preoperative prepara-
tion before the patient arrives, may improve results to a certain de-
gree. Nevertheless, there can be no doubt that screening for AAA
and elective operation will give much better results than even the
most efﬁcient transfer system for patients with rAAA and should be
implemented as soon as possible.3-5 The screening algorithm, how-
ever, may have to be adapted due to changing epidemiology.6
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Reply
Our study is the ﬁrst to describe population level outcomes in
the United States, and we appreciate the references provided by Dr
Altreuther describing a European experience. It is noteworthy that
the ﬁndings of both studies are quite similar, despite differences in
health care delivery systems, geography, and distances. We also
agree that the best treatment for ruptured abdominal aortic aneu-
rysm (rAAA) is prevention, with early detection and effective sur-
veillance.1,2 For those who present with rAAA and cannot receive
treatment at the initial presenting facility, we found that the ben-
eﬁts of transfer for repair appear to be eclipsed by those who die
en route or after arrival to the receiving hospital without receiving
